Relay Therapeutics Inc (RLAY) Stocks Reach New Highs at $9.50 During Trading Session

After finishing at $10.32 in the prior trading day, Relay Therapeutics Inc (NASDAQ: RLAY) closed at $9.50, down -7.95%. In other words, the price has decreased by -$0.82 from its previous closing price. On the day, 1378056 shares were traded. RLAY stock price reached its highest trading level at $10.51 during the session, while it also had its lowest trading level at $9.44.

Ratios:

Our goal is to gain a better understanding of RLAY by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 25.44 and its Current Ratio is at 25.44. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.

On April 19, 2023, Raymond James Upgraded its rating to Strong Buy which previously was Outperform but kept the price unchanged to $29.

On April 13, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $29.Raymond James initiated its Outperform rating on April 13, 2023, with a $29 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 29 ’24 when Bergstrom Donald A sold 3,178 shares for $9.64 per share. The transaction valued at 30,636 led to the insider holds 530,878 shares of the business.

Catinazzo Thomas sold 2,005 shares of RLAY for $19,328 on Jan 29 ’24. The Chief Financial Officer now owns 341,846 shares after completing the transaction at $9.64 per share. On Jan 29 ’24, another insider, Adams Brian, who serves as the Chief Legal Officer of the company, sold 1,929 shares for $9.64 each. As a result, the insider received 18,596 and left with 327,738 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 1.35B and an Enterprise Value of 657.15M. For the stock, the TTM Price-to-Sale (P/S) ratio is 48.78 while its Price-to-Book (P/B) ratio in mrq is 1.61. Its current Enterprise Value per Revenue stands at 25.72 whereas that against EBITDA is -1.76.

Stock Price History:

Over the past 52 weeks, RLAY has reached a high of $19.23, while it has fallen to a 52-week low of $5.95. The 50-Day Moving Average of the stock is 10.24, while the 200-Day Moving Average is calculated to be 10.03.

Shares Statistics:

The stock has traded on average 1.02M shares per day over the past 3-months and 885.54k shares per day over the last 10 days, according to various share statistics. A total of 127.46M shares are outstanding, with a floating share count of 92.20M. Insiders hold about 29.71% of the company’s shares, while institutions hold 71.64% stake in the company. Shares short for RLAY as of Feb 15, 2024 were 9.81M with a Short Ratio of 9.66, compared to 11.29M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.70% and a Short% of Float of 9.99%.

Earnings Estimates

Its stock is currently analyzed by 8 different market analysts. On average, analysts expect EPS of -$0.71 for the current quarter, with a high estimate of -$0.67 and a low estimate of -$0.81, while EPS last year was -$0.78. The consensus estimate for the next quarter is -$0.74, with high estimates of -$0.68 and low estimates of -$0.86.

Analysts are recommending an EPS of between -$2.59 and -$3.33 for the fiscal current year, implying an average EPS of -$2.93. EPS for the following year is -$2.8, with 9 analysts recommending between -$2.31 and -$3.11.

Most Popular

[the_ad id="945"]